Decrease of Normotest/Thrombotest discrepancy in non-contacted coumarin plasma after glass or ellagic acid activation

[1]  J. Kop,et al.  Kinetic Aspects of the interaction of Blood Clotting Enzymes III . Demonstration of an Inhibitor of Prothrombin Conversion in Vitamin K Deficiency , 2007 .

[2]  A. Girolami,et al.  Dilution curve studies in prothrombin complex factors deficiencies and abnormalities , 1974, Blut.

[3]  A. Girolami,et al.  Dilution curves studies in coumarin plasmas and in artificially depleted abnormal control plasmas , 1974, Blut.

[4]  A. Girolami,et al.  Normotest--thrombotest discrepancy in congenital coagulation disorders of the prothrombin complex and in coumarin-treated patients: a nonspecific phenomenon. , 1977, American journal of clinical pathology.

[5]  J. German,et al.  MONGOLISM BY TERTIARY TRISOMY , 1975, The Lancet.

[6]  K. Laake,et al.  Progressive inactivation of factor VII in the cold by heparin. , 1974, Thrombosis research.

[7]  H. Godal,et al.  Discrepancy between thrombotest and normotest--an indicator of disseminated intravascular coagulation (DIC)? , 2009, Scandinavian journal of haematology.

[8]  M. Jeremić,et al.  Discrepancy between normotest and thrombotest during thromboplastin induced intravascular coagulation in rabbits. , 2009, Scandinavian journal of haematology.

[9]  H. Hemker,et al.  Lack of PIVKA effect in the abnormal factor X (factor X Friuli) coagulation disorder. , 1972, Haemostasis.

[10]  H. Godal,et al.  Activation of coagulation by heparin-protamine complexes as demonstrated by thrombotest. , 2009, Scandinavian journal of haematology.

[11]  P. Kierulf,et al.  Thrombotest and the diagnosis of disseminated intravascular coagulation (DIC). , 2009, Scandinavian journal of haematology.

[12]  A. Girolami,et al.  Congenital Afibrinogenemia , 1971, Thrombosis and Haemostasis.

[13]  A. Girolami,et al.  Ellagic acid induced thromboelastographic changes in the normal individual and in several coagulopathies. , 1969, Haematologica Latina.

[14]  S. Béguin,et al.  The Possible Role of Factor VII in the Intrinsic System , 1969 .

[15]  H. Hemker,et al.  Kinetic aspects of the interaction of blood clotting enzymes , 2007 .

[16]  H. Hemker,et al.  Kinetic Aspects of the Interaction of Blood Clotting Enzymes , 1968, Thrombosis and Haemostasis.

[17]  P. Mannucci,et al.  An investigation of three patients with Christmas disease due to an abnormal type of factor ix , 1968, Journal of clinical pathology.

[18]  J. Soulier,et al.  Différents états moléculaires du facteur II (prothrombine). Leur étude à l’aide de la staphylocoagulase et d’anticorps anti-facteur II , 1968, Thrombosis and Haemostasis.

[19]  C. Hougie,et al.  Haemophilia Bm: a new type of factor-IX deficiency. , 1967, Lancet.

[20]  A. Girolami,et al.  Hypercoagulable State Induced in Humans by the Intravenous Administration of Purified Ellagic Acid , 1967, Thrombosis and Haemostasis.

[21]  J. Shanberge,et al.  Studies Regarding the Effect of Foreign-Surface Contact on the One-Stage Prothrombin Time Determination , 1966, Thrombosis and Haemostasis.

[22]  M. Verstraete,et al.  THROMBOTEST REAGENT AND CHRISTMAS DISEASE. , 1964, Lancet.

[23]  F. Nour-Eldin.  THROMBOTEST REAGENT AND CHRISTMAS DISEASE , 1963 .

[24]  P. Owren.  Control of anticoagulant therapy. The use of new tests. , 1963, Archives of internal medicine.

[25]  H. Hemker,et al.  Behaviour of Factors II, VII, IX and X in Bleeding Complications During Long-Term Treatment with Coumarin , 1963, Thrombosis and Haemostasis.

[26]  C. Hussey,et al.  Comparison of the thrombotest with the one-stage prothrombin time. , 1961, The New England journal of medicine.

[27]  P. Owren.  Thrombotest. A new method for controlling anticoagulant therapy. , 1959, Lancet.

[28]  W. Walther,et al.  The control of anticoagulant therapy. , 1951, Lancet.